Geneva, November 2011 Quality Assurance Policy for Pharmaceutical Products Clinical Criteria Medicines listed in WHO or national or institutional Standard Treatment Guidelines Quality Criteria For all products: Authorized for use in recipient countries For ARVs, anti-TB and anti-malarial products: WHO Prequalified or authorized by a Stringent Regulatory Authorities; OR Recommended for use by Expert Review Panel Monitoring Quality Monitoring quality of products all along the supply chain Systematic random quality control testing Recipients report testing results to Global Fund + +
{}